STIM

STIM

Neuronetics Inc

Revenue grew 100% of years5Y
Hold

Neuronetics, Inc. develops and markets the NeuroStar Advanced Therapy System, a non-invasive treatment for major depressive disorder using transcranial magnetic stimulation. The system targets brain areas related to mood and is sold primarily to psychiatrists.

โš•๏ธ Healthcare NASDAQ Listed 2018 $ USD
$1,000 invested 5 years ago โ†’$370today

Score Overview

1 Year
Score
Net Growth4.83%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth1.66%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.0
Net Growth-18.98%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth174.15%
Rev TrendEvery year
Revenue Consistencyโ€”
All Time
Score
Net Growth-54.02%
Net Trend50%
Net Income Consistency
Rev Growth187.32%
Rev Trend88%
Revenue Consistency

See the full market ranking โ†’

Neuronetics Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 49M to $ 149M and net income went from -$ 27M to -$ 38M. Revenue increased in every one of those 5 years; net income in 3.

Neuronetics Inc currently holds a 5-year HDB Score of 6.0 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 3.21โ€”
1 Year2025-08-12
$ 3.86-16.84%
5 Years2021-08-12
$ 8.68-63.02%
All Time2018-06-28
$ 27.78-88.44%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 151M-$ 37M$ 13M
2025$ 149M-$ 38M$ 34M
2024$ 74M-$ 43M$ 19M
2023$ 71M-$ 30M$ 60M
2022$ 65M-$ 37M$ 71M
2021$ 55M-$ 31M$ 96M
2020$ 49M-$ 27M$ 50M
2019$ 62M-$ 29M$ 76M
IPO2018$ 52M-$ 24M$ 104M

Explore beyond STIM

You're looking at Neuronetics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies